Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Keros Therapeutics adjusts TROPOS trial of cibotercept amid safety concerns Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced significant changes to its Phase 2 TROPOS trial evaluating… byPallavi MadhirajuDecember 12, 2024